Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 200533

Expand all

NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
EQ 50MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N200533
Product Number: 001
Approval Date: Aug 25, 2011
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
EQ 100MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N200533
Product Number: 002
Approval Date: Aug 25, 2011
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N200533
Product Number: 003
Approval Date: Aug 25, 2011
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
EQ 200MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N200533
Product Number: 004
Approval Date: Aug 25, 2011
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
EQ 250MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA ER
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 250MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N200533
Product Number: 005
Approval Date: Aug 25, 2011
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English